Structural Immunology of CD1 and CD1-TCR Complexes
CD1 和 CD1-TCR 复合物的结构免疫学
基本信息
- 批准号:8019102
- 负责人:
- 金额:$ 40.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-03-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:1,2-diacylglycerolAddressAdjuvantAmino AcidsAntibodiesAntigen PresentationAntigen ReceptorsAntigen-Presenting CellsAntigensAutoantigensAutoimmune DiseasesAutoimmunityBindingBiochemicalBiological ModelsBiologyBorrelia burgdorferiBrainCD1 AntigensCD4 Positive T LymphocytesCellsCellular ImmunityCeramidesComplexCrystallographyCytotoxic T-LymphocytesDataDevelopmentDiglyceridesDiseaseDockingEpitopesExperimental Autoimmune EncephalomyelitisFutureGalactosylceramidesGlycerolGlycolipidsGlycosphingolipidsGoalsHealthHelper-Inducer T-LymphocyteHexosesHost DefenseHumanHybridomasImmuneImmune responseImmune systemImmunologyInfectionInfectious AgentKineticsLightLinkLipidsLyme DiseaseLymphocyteMHC Class I GenesMeasuresModelingModificationMolecularMolecular StructureMultiple SclerosisMusMutagenesisOrder SpirochaetalesOrganismOutcomePeptidesPhospholipidsPlayProductionPropertyRecruitment ActivityRoentgen RaysRoleSeriesSideSpecificityStructureSulfoglycosphingolipidsSurface Plasmon ResonanceT-Cell ActivationT-Cell ReceptorT-LymphocyteTCR ActivationType II Epithelial Receptor CellVertebral columnantigen bindingbasecarbenecell typechemotherapeutic agentcombatcytokinefield studyinsightinterestkillingslipid structuremicrobialmicroorganism antigennovelpreferencepublic health relevanceresponsesugarthree dimensional structuretumorunsaturated bonds
项目摘要
DESCRIPTION (provided by applicant): Over the past 10 years, a tremendous amount of data has accumulated, which demonstrates the role of glycolipid-reactive T cells in autoimmune disease, host defense and tumor development. T cells and NKT cells can respond to a broad pool of self and foreign antigens presented by CD1 molecules and can trigger killing of the antigen presenting cell, through cytotoxic T lymphocytes (CTLs), or recruit help (T helper cells) from the humoral immune system through production of soluble antibodies. Our lab is interested in the molecular mechanisms of lipid antigen recognition in cell-mediated immunity. Toward this goal, we determine the binding kinetics of various glycolipid- reactive T cell receptor's (TCR's) with various CD1 antigen-presenting molecules by surface plasmon resonance studies (SPR). We will further correlate the obtained results with data obtained by measuring cytokine production upon T cell activation using T cell hybridomas. Ultimately we propose to determine the three-dimensional structure of CD1 antigen receptors in complex with different lipids and cognate T cell receptors (TCR's) by x-ray crystallography. We specifically address the following specific aims: 1) What are the biochemical and functional properties of human and mouse sulfatide-reactive NKT cells. We will determine the structure of sulfatide loaded human CD1a and mouse CD1d in complex with the respective TCR and characterize their binding kinetics by SPR. Comparisons of both complexes will provide insights into the similarities and disparities of sulfatide recognition by the immune system and will shed light on the molecular mechanism of their activation. 2) We will structurally and functionally characterize differences in glycolipid recognition of Borrelia burgdorferi glycolipids by human and mouse NKT cells. 3) We will characterize binding of novel endogenous self-lipids to mouse CD1d and their recognition by NKT cells. Structural insights into the differences of self vs. microbial antigen presentation will help understand the role of microbial lipids and lipid-reactive T cells in host defense and autoimmune diseases. Public Health Relevance: NKT cells are specialized lymphocytes that consist of several subtypes and can respond to glycolipids from infectious organisms, such as Borrelia burgdorferi the causative agent of Lyme disease and self-lipids, during the course of autoimmune disease such as Multiple sclerosis. Understanding the functional properties of these cell types at a molecular level is crucial for the future development of novel chemotherapeutic agents or adjuvants to combat both diseases.
描述(申请人提供):在过去的10年里,积累了大量的数据,证明了糖脂反应性T细胞在自身免疫性疾病、宿主防御和肿瘤发展中的作用。T细胞和NKT细胞可以对CD1分子呈递的大量自身和外来抗原做出反应,并可以通过细胞毒性T淋巴细胞(CTL)触发对抗原提呈细胞的杀伤,或者通过产生可溶性抗体从体液免疫系统中招募HELP(T辅助细胞)。我们实验室对细胞免疫中脂抗原识别的分子机制很感兴趣。为此,我们通过表面等离子体共振研究(SPR)来确定不同糖脂反应性T细胞受体(TCR)与不同CD1抗原提呈分子的结合动力学。我们将进一步将获得的结果与使用T细胞杂交瘤测量T细胞激活时细胞因子产生的数据相关联。最终,我们建议用X射线结晶学的方法来确定不同脂类和同源T细胞受体(TCR)的复合体中CD1抗原受体的三维结构。我们专门针对以下具体目标:1)人和小鼠硫脂反应性NKT细胞的生化和功能特性是什么。我们将测定硫脂负载的人CD1a和小鼠CD1d与各自的TCR的络合物的结构,并用SPR表征它们的结合动力学。对这两种复合体的比较将提供对免疫系统识别硫脂的相似性和差异性的见解,并将阐明它们激活的分子机制。2)我们将从结构和功能上研究人和小鼠NKT细胞识别伯氏疏螺旋体糖脂的差异。3)我们将研究新型内源性自体脂质与小鼠CD1d的结合及其对NKT细胞的识别作用。对自身和微生物抗原提呈的差异的结构性洞察将有助于理解微生物脂类和脂质反应性T细胞在宿主防御和自身免疫性疾病中的作用。公共卫生相关性:NKT细胞是一种特殊的淋巴细胞,由几个亚型组成,在多发性硬化症等自身免疫性疾病的过程中,可以对来自感染性生物的糖脂产生反应,例如莱姆病的病原体伯氏疏螺旋体和自身脂质。在分子水平上了解这些细胞类型的功能特性对于未来开发抗击这两种疾病的新型化疗药物或佐剂至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dirk M Zajonc其他文献
A 'GEM' of a cell
细胞中的“珍宝”
- DOI:
10.1038/ni.2644 - 发表时间:
2013-06-18 - 期刊:
- 影响因子:27.600
- 作者:
Mitchell Kronenberg;Dirk M Zajonc - 通讯作者:
Dirk M Zajonc
Dirk M Zajonc的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dirk M Zajonc', 18)}}的其他基金
Design and evaluation of HLA-A, -B, and -C binding peptides that disrupt inhibitory KIR/MHC interaction and activate NK cells
设计和评估 HLA-A、-B 和 -C 结合肽,破坏抑制性 KIR/MHC 相互作用并激活 NK 细胞
- 批准号:
9227710 - 财政年份:2016
- 资助金额:
$ 40.36万 - 项目类别:
Structural basis of UL141 mediated NK cell inhibition by HCMV
HCMV 介导的 UL141 介导的 NK 细胞抑制的结构基础
- 批准号:
8873656 - 财政年份:2015
- 资助金额:
$ 40.36万 - 项目类别:
Structure and function of peptide presentation by CD1d
CD1d 肽呈递的结构和功能
- 批准号:
8569883 - 财政年份:2013
- 资助金额:
$ 40.36万 - 项目类别:
STRUCTURAL STUDIES OF GLYCOLIPID-REACTIVE T CELLS AND ANTIBODIES
糖脂反应性 T 细胞和抗体的结构研究
- 批准号:
8362144 - 财政年份:2011
- 资助金额:
$ 40.36万 - 项目类别:
STRUCTURAL STUDIES OF GLYCOLIPID-REACTIVE T CELLS AND ANTIBODIES
糖脂反应性 T 细胞和抗体的结构研究
- 批准号:
8170083 - 财政年份:2010
- 资助金额:
$ 40.36万 - 项目类别:
Structural Immunology of CD1 and CD1-TCR Complexes
CD1 和 CD1-TCR 复合物的结构免疫学
- 批准号:
8214630 - 财政年份:2009
- 资助金额:
$ 40.36万 - 项目类别:
STRUCTURAL STUDIES OF GLYCOLIPID-REACTIVE T CELLS AND ANTIBODIES
糖脂反应性 T 细胞和抗体的结构研究
- 批准号:
7954410 - 财政年份:2009
- 资助金额:
$ 40.36万 - 项目类别:
Structural Immunology of CD1 and CD1-TCR Complexes
CD1 和 CD1-TCR 复合物的结构免疫学
- 批准号:
7769934 - 财政年份:2009
- 资助金额:
$ 40.36万 - 项目类别:
Structural Immunology of CD1 and CD1-TCR Complexes
CD1 和 CD1-TCR 复合物的结构免疫学
- 批准号:
8427352 - 财政年份:2009
- 资助金额:
$ 40.36万 - 项目类别:
Structural Immunology of CD1 and CD1-TCR Complexes
CD1 和 CD1-TCR 复合物的结构免疫学
- 批准号:
7655604 - 财政年份:2009
- 资助金额:
$ 40.36万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 40.36万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 40.36万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 40.36万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 40.36万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 40.36万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 40.36万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 40.36万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 40.36万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 40.36万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 40.36万 - 项目类别:
Research Grant














{{item.name}}会员




